MOONLAKE IMMUNOTHERAPEUTICS Income Taxes Paid
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) reported Income Taxes Paid of $799.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-25
- MOONLAKE IMMUNOTHERAPEUTICS income taxes paid, net for the quarter ending 2025-12-31 was $733.00K, a 412.59% increase year-over-year.
- MOONLAKE IMMUNOTHERAPEUTICS income taxes paid, net for the quarter ending 2024-12-31 was $143.00K.
- MOONLAKE IMMUNOTHERAPEUTICS income taxes paid, net for fiscal 2025 was $799.00K, a 443.54% increase from fiscal 2024.
- MOONLAKE IMMUNOTHERAPEUTICS income taxes paid, net for fiscal 2024 was $147.00K, a 250.00% increase from fiscal 2023.
- MOONLAKE IMMUNOTHERAPEUTICS income taxes paid, net for fiscal 2023 was $42.00K, a 874.03% increase from fiscal 2022.
- MOONLAKE IMMUNOTHERAPEUTICS income taxes paid, net for fiscal 2022 was $4.31K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 10 month | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $733.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $799.00K 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $66.00K 10-Q · filed 2025-11-05 | ||||
| 2024-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $147.00K 10-K · filed 2026-02-25 | $147.29K 10-K · filed 2025-02-26 | ||
| 2024-09-30 | $4.00K 10-Q · filed 2025-11-05 | ||||
| 2023-12-31 | $42.00K 10-K · filed 2026-02-25 | $41.71K 10-K · filed 2024-02-29 | |||
| 2022-12-31 | $4.31K 10-K · filed 2025-02-26 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |